Topical Interferon Alpha-2b Induced Reactive Lymphoid Hyperplasia Masquerading as Orbital Extension of Ocular Surface Squamous Neoplasia

Cornea
Graham A LeeKevin Whitehead

Abstract

The use of topical interferon alpha-2b is a well-established treatment for ocular surface squamous neoplasia. There have been numerous reports on its efficacy and high safety profile. Benign reactive lymphoid hyperplasia in ocular tissues has not been previously documented by histopathology after interferon treatment. This case report describes a 55-year-old man who had successful resolution of his ocular surface squamous neoplasia after topical treatment, but developed forniceal tissue deposits. The appearance of the lesions was unexpected and alerted the clinician to the possibility of further neoplastic extension. Excisional biopsy of the lesions confirmed benign reactive lymphoid hyperplasia and resolved with no recurrence.

Citations

Apr 6, 2019·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Natalia LewczukJoanna Bogusławska
Jul 22, 2018·Ophthalmology and Therapy·Maria Vittoria CicinelliGiulio Modorati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Indian Journal of Ophthalmology
Erick Hernandez-BogantesEnrique O Graue-Hernández
The British Journal of Ophthalmology
Anthony J Aldave, Anne Nguyen
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
Salomon Esquenazi
© 2022 Meta ULC. All rights reserved